MedPath

Clinical Observation of Yiqi Joint Venture Traditional Chinese Medicine Combined with Precise Minimally Invasive Debridement in the Treatment of Granulomatous Lobular Mastitis

Phase 1
Conditions
Granulomatous lobular mastitis
Registration Number
ITMCTR2100005217
Lead Sponsor
The Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Non pregnant and lactating female patients;
2. The pathological diagnosis was granulomatous mastitis in the stage of mass or abscess;
3. Female patients over 18 years old (including 18 years old) and under 50 years old;
4. Volunteer to participate in the trial and sign the informed consent;
5. Be able to cooperate with researchers to complete the investigation.

Exclusion Criteria

1. TB infected T cells (ESAT-6, CFP-10), PDD tuberculin test suspected breast tuberculosis patients;
2. Unable to take hormone due to physical or other reasons;
3. Patients with other immune related diseases;
4. Patients with severe primary diseases such as cardiovascular, cerebrovascular, kidney, liver, endocrine system and hematopoietic system, mental patients, or mental or legal disabilities;
5. According to the judgment of the researchers, other diseases that reduce the possibility of enrollment or complicate the enrollment, such as frequent changes in the working environment, are likely to cause loss of follow-up, and those who cannot give full informed consent due to mental and behavioral disorders.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of disease;Recurrence rate;Patient satisfaction after cure;Ultrasound imaging of breast;The effective rate of conservative treatment;Operation method;laboratory examination;Breast symptoms;The aesthetic degree of breast appearance;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath